MENS
Jyong Biotech Ltd. Ordinary Shares
NASDAQ: MENS · HEALTHCARE · BIOTECHNOLOGY
$2.18
+0.46% today
Updated 2026-04-29
Market cap
$164.98M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.04
Dividend yield
—
52W range
$1 – $67
Volume
0.2M
Jyong Biotech Ltd. Ordinary Shares (MENS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Operating cash flow | $-1.09M | $-1.98M | $-2.97M | $-2.60M | $-3.62M |
| Capital expenditures | $88000.00 | $137000.00 | $246000.00 | $0.00 | $0.00 |
| Depreciation | $110000.00 | $122000.00 | $123000.00 | $127000.00 | $120000.00 |
| Stock-based comp | — | — | — | — | — |
| Free cash flow | $-1.18M | $-2.12M | $-3.22M | $-2.60M | $-3.62M |
| Investing cash flow | $731000.00 | $-1.31M | $1.39M | $95000.00 | — |
| Financing cash flow | $4.91M | $-1.38M | $3.33M | $2.03M | $1.99M |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |